Rating Change
Truist Securities reiterated its Buy rating on Upstream Bio, Inc. (NASDAQ:UPB) on August 12, 2026.
reiterateNASDAQ:UPB
Truist Securities Reiterates Buy Rating on Upstream Bio, Inc. (UPB)
Truist Securities reiterated its Buy rating on Upstream Bio, Inc. (NASDAQ:UPB) on August 12, 2026.
At publication ·
What changed
Upstream Bio, Inc. (NASDAQ:UPB) · reiterate
- Firm
- Truist Securities
- Rating
- Buy to Buy
- Price at event
- $6.91
- Market capitalization
- $1.5B
At a glance
Key takeaways
- Truist Securities reiterated a Buy rating on Upstream Bio (UPB) on August 12, 2026, with the stock trading at $6.91 and a market capitalization of $1.5 billion.
Market Context
Upstream Bio, Inc. operates in the Healthcare sector. The stock currently trades at $6.91 with a market capitalization of $1.5B.
Analyst coverage from Truist Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Upstream Bio, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Upstream Bio, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 12, 2026 | Truist Securities | Buy | N/A |
| Jun 12, 2026 | JP Morgan | Neutral | N/A |
| Jun 03, 2026 | HC Wainwright & Co. | Buy | N/A |
| May 14, 2026 | Mizuho | Outperform | N/A |
| Mar 27, 2026 | Evercore ISI Group | In-Line | N/A |
Related Tools: Analyst Ratings Dashboard | View UPB Stock Page
Frequently Asked Questions
What does the Buy rating mean for UPB?
A rating of Buy from Truist Securities reflects the analyst's outlook on Upstream Bio, Inc. (NASDAQ:UPB). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the UPB forecast page.